Sequenom (NASDAQ:SQNM) confirmed today at the Jefferies conference that they had signed two new international technology transfer agreements. They said they would disclose the countries and partners at a future date. These agreements will allow processing of tests locally, similar to the Life Codexx and Lab Cerba agreements in Germany and France.
I suspect one of these agreements is with Dr Lo in Hong Kong. They did not state why they were not able to disclose the partners currently, though it is likely to allow the partner to control the public relations release in the market.
Disclosure: I am long SQNM.